Avacta Life Sciences Ltd clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   AVA6000 in Solid Tumours

   Enrollment closed, study ongoing

   Also in this update: Primary completion date changed from estimate of Jun 15, 2026 to Aug 7, 2026; Study completion pushed from Aug 15, 2026 to Aug 6, 2027

   Avacta Life Sciences Ltd·Phase 1· NCT04969835· Registry history of NCT04969835 on ClinicalTrials.gov (opens the registry)

   Updated Oct 2, 2026

2. Minor

   FOCUS-01 · AVA6103 · Locally Advanced or Metastatic Selected…FOCUS-01 · AVA6103 · Locally Advanced or Metastatic Selected Solid Tumors

   Trial sites expanded: 3 → 7 locations

   Avacta Life Sciences Ltd·Phase 1· NCT07454642· Registry history of NCT07454642 on ClinicalTrials.gov (opens the registry)

   Updated Oct 5, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.